Literature DB >> 9782004

Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer.

M Tisch1, F Heimlich, V Daniel, G Opelz, H Maier.   

Abstract

The effects of locoregional postoperative radiation therapy (60 Gy on average) on cellular immunity were investigated in 11 patients with squamocellular carcinomas of the oral cavity, pharynx, or larynx. During radiation treatment, the total lymphocyte counts, CD8+ T-lymphocyte count, and especially CD4+ T-lymphocyte count decreased significantly. The mean CD4+ T-lymphocyte counts dropped from an average of 739/microl to 183/microl (p <0.001), and the CD4+/CD8+ quotient also decreased significantly. Not only the lymphocyte counts but also the in vitro lymphocyte stimulation responses to several mitogens decreased, with reductions averaging 10% to 50% of normal responses by the end of radiation therapy. Within 3 to 4 weeks after radiation therapy, the CD4+ T-lymphocyte counts and the in vitro lymphocyte stimulation responses showed a tendency toward normalization. This study shows that postoperative locoregional radiation therapy in patients with head and neck cancer induces a severe generalized impairment of cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9782004     DOI: 10.1016/S0194-5998(98)70092-0

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

Review 1.  [Antitumour vaccination in patients with ENT tumours. Successful track record].

Authors:  G Dyckhoff; C Herold-Mende
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

2.  Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.

Authors:  Jian L Campian; Guneet Sarai; Xiaobu Ye; Shanthi Marur; Stuart A Grossman
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

3.  Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.

Authors:  Falguni Parikh; Dorothée Duluc; Naoko Imai; Amelia Clark; Krzys Misiukiewicz; Marcello Bonomi; Vishal Gupta; Alexis Patsias; Michael Parides; Elizabeth G Demicco; David Y Zhang; Seunghee Kim-Schulze; Johnny Kao; Sacha Gnjatic; Sangkon Oh; Marshall R Posner; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-10-15       Impact factor: 12.701

4.  Growth hormone protects human lymphocytes from irradiation-induced cell death.

Authors:  Laurence Lempereur; Daria Brambilla; Giovanna Maria Scoto; Maria D'Alcamo; Vincent Goffin; Lucia Crosta; Tullio Palmucci; Liborio Rampello; Renato Bernardini; Giuseppina Cantarella
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Prolonged severe immunodeficiency following thymectomy and radiation: a case report.

Authors:  Johanna Lee Wickemeyer; Sudhir Sekhsaria
Journal:  J Med Case Rep       Date:  2014-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.